Screener
Medline, Inc. MDLN Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $7.69B+11.6% | $7.35B+10.7% | —— | —— | $6.89B+8.0% | ||
| $5.47B+9.8% | $5.51B+14.3% | —— | —— | $4.98B+7.5% | ||
| $2.22B+16.3% | $1.84B+0.9% | —— | —— | $1.91B+9.2% | ||
| 28.8%+1.2pp | 25%-2.4pp | —— | —— | 27.7%+0.3pp | ||
| —— | —— | $20M+19.4% | $20M+19.4% | $20M+19.4% | ||
| $1.3B+20.7% | $1.23B+14.8% | —— | —— | $1.07B+4.5% | ||
| $1.82B+44.1% | $1.42B+13.2% | —— | —— | $1.26B+4.6% | ||
| $395M-38.5% | $422M-26.1% | —— | —— | $642M+19.7% | ||
| 5.1%-4.2pp | 5.7%-2.9pp | —— | —— | 9.3%+0.9pp | ||
| $168M-33.6% | $165M-32.4% | —— | —— | $253M-11.5% | ||
| -$160M+43.5% | -$131M+43.8% | —— | —— | -$283M-25.8% | ||
| $235M-34.5% | $291M-13.9% | —— | —— | $359M+15.2% | ||
| $96M+269% | $52M+225% | —— | —— | $26M+126% | ||
| $139M-57.8% | $239M-25.1% | -$7M-102% | $518M+78.2% | $329M+13.2% | ||
| 1.8%-3.0pp | 3.3%-1.6pp | —— | —— | 4.8%+0.2pp | ||
| $0.07— | $0.16— | -$0.01— | —— | —— | ||
| $651M-27.0% | $676M-17.4% | —— | —— | $892M+14.2% | ||
| 8.5%-4.5pp | 9.2%-3.1pp | —— | —— | 13%+0.7pp | ||
| $395M-38.5% | $422M-26.1% | —— | —— | $642M+19.7% |
FAQ
- What is Medline, Inc.'s revenue?
- Medline, Inc. (MDLN) generated $28.6B in revenue over the trailing twelve months, up 12.0% year over year.
- Is Medline, Inc. profitable?
- Medline, Inc. reported $889.0M in net income over the trailing twelve months, a 4.7% net margin.
- What are Medline, Inc.'s profit margins?
- Gross margin is 27.5% and operating margin is 8.7%, with a 4.7% net margin.
- Where does Medline, Inc.'s income statement data come from?
- Every line is extracted from Medline, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
